Jay Siegel's most recent trade in Macrogenics Inc was a trade of 16,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 21, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Macrogenics Inc | Jay Siegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
Macrogenics Inc | Jay Siegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 6,500 | 6,500 | - | - | Restricted Stock Unit | |
Macrogenics Inc | Jay Siegel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 4,500 | 4,500 (0%) | 0% | 0 | Common Stock | |
Macrogenics Inc | Jay Siegel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 4,500 | 0 | - | - | Restricted Stock Unit | |
Macrogenics Inc | Jay Siegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 24,080 | 24,080 | - | - | Stock Option (right to buy) | |
Macrogenics Inc | Jay Siegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
Macrogenics Inc | Jay Siegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) |